Skip to content
10-K

Annual Report

Edgewise Therapeutics, Inc. EWTX

0001558370-25-002006

← back to feed
Filed
Mar 3, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 24, 2025 95.21M sh
Cash And Equivalents FY 2024 · Dec 31, 2023 $86.1M
Current Liabilities FY 2024 · Dec 31, 2023 $16.77M
Total Liabilities FY 2024 · Dec 31, 2023 $21.21M
Current Assets FY 2024 · Dec 31, 2023 $327M
Total Assets FY 2024 · Dec 31, 2023 $340.04M